Bruker Corp (BRKR)
70.04
-0.04
(-0.06%)
USD |
NASDAQ |
May 03, 16:00
70.06
+0.01
(+0.01%)
Pre-Market: 20:00
Bruker Accounts Receivable (Quarterly): 475.40M for March 31, 2024
Accounts Receivable (Quarterly) Chart
Historical Accounts Receivable (Quarterly) Data
Date | Value |
---|---|
March 31, 2024 | 475.40M |
December 31, 2023 | 492.00M |
September 30, 2023 | 485.40M |
June 30, 2023 | 450.80M |
March 31, 2023 | 471.70M |
December 31, 2022 | 472.70M |
September 30, 2022 | 421.30M |
June 30, 2022 | 402.60M |
March 31, 2022 | 413.80M |
December 31, 2021 | 416.90M |
September 30, 2021 | 372.10M |
June 30, 2021 | 337.00M |
March 31, 2021 | 326.00M |
December 31, 2020 | 335.30M |
September 30, 2020 | 329.90M |
June 30, 2020 | 324.50M |
March 31, 2020 | 325.50M |
December 31, 2019 | 362.20M |
September 30, 2019 | 358.80M |
June 30, 2019 | 348.00M |
March 31, 2019 | 360.40M |
December 31, 2018 | 357.20M |
September 30, 2018 | 323.40M |
June 30, 2018 | 278.80M |
March 31, 2018 | 313.60M |
Date | Value |
---|---|
December 31, 2017 | 319.30M |
September 30, 2017 | 269.80M |
June 30, 2017 | 240.40M |
March 31, 2017 | 225.40M |
December 31, 2016 | 243.90M |
September 30, 2016 | 223.60M |
June 30, 2016 | 206.90M |
March 31, 2016 | 233.40M |
December 31, 2015 | 234.70M |
September 30, 2015 | 242.30M |
June 30, 2015 | 240.30M |
March 31, 2015 | 227.60M |
December 31, 2014 | 293.20M |
September 30, 2014 | 268.90M |
June 30, 2014 | 279.60M |
March 31, 2014 | 295.00M |
December 31, 2013 | 307.60M |
September 30, 2013 | 297.70M |
June 30, 2013 | 300.50M |
March 31, 2013 | 273.40M |
December 31, 2012 | 289.30M |
September 30, 2012 | 264.80M |
June 30, 2012 | 248.80M |
March 31, 2012 | 261.80M |
December 31, 2011 | 282.80M |
Accounts Receivable Definition
Account used to record sales made "on account", meaning that the company has made a sale but has not collected payment. When company collects cash as payment, the corresponding account receivable is decreased.
Accounts Receivable (Quarterly) Range, Past 5 Years
324.50M
Minimum
Jun 2020
492.00M
Maximum
Dec 2023
396.10M
Average
387.35M
Median
Accounts Receivable (Quarterly) Benchmarks
Azenta Inc | 155.93M |
Harvard Bioscience Inc | 16.10M |
Bionano Genomics Inc | 9.319M |
Akoya Biosciences Inc | 16.99M |
Singular Genomics Systems Inc | 0.565M |